4,7 In this regard, this addition ensures a more comprehensive discussion aligned with current expert consensus on risk mitigation strategies
[10] [11] Small clinical trials of liraglutide in HFrEF (FIGHT and LIVE) have shown heart rate increases and potential safety signals, suggesting caution in this population
In most studies, the adverse events did not lead to treatment discontinuation ( An intensive discussion on the pancreatic safety of incretin-based therapies initiated by publications of a single group have led to a thorough evaluation of non-clinical and clinical data by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) ( Regarding skin lesions, bullous pemphigoid, a rare autoimmune skin disease, was found to be associated with the use of DPP-4 inhibitors in a retrospective analysis of more than 9,000 patients treated in Japan during the years 20092017
Compounded GLP-1 therapy is used for weight loss to help address health concerns associated with being overweight or obese, to reduce the overall risk of developing one or more of these issues
doi: 10.1111/dom.12414 38 AhrnBJohnsonSLStewartMCirkelDTYangFPerryCet al
